Latest Nutrition News


Pizza Study Shows Body's Resilience to 'Pigging Out'

Pizza Study Shows Body`s Resilience to `Pigging Out`FRIDAY, Aug. 7, 2020 (HealthDay News) -- Ever felt guilty for that occasional binge on high-calorie, fatty foods? Relax: A new study of folks overindulging on pizza finds that if you're healthy and you don't 'pig out' regularly, your body deals with it just fine. British researchers looked at the effects of eating until not just full, but so full that the participants could not take another bite. Then, they tested the blood of the 14 healthy young men who participated in the study to determine whether there were any changes in blood sugar, blood fats, insulin and other hormones. The team discovered that even when the men had eaten double the amount of pizza that it would take to make them comfortably full, their blood tests showed no negative consequences. "I think that's the...

Two Common Nutrients Might Keep Vertigo at Bay

5 August 2020
Two Common Nutrients Might Keep Vertigo at BayWEDNESDAY, Aug. 5, 2020 (HealthDay News) -- Taking in extra vitamin D plus calcium might cut your odds of getting a debilitating form of vertigo, new research shows. The Korean study focused on benign paroxysmal positional vertigo (BPPV), a sudden spinning sensation that's commonly triggered by changing your head position. According to the study authors, about 86% of people who have this type of vertigo find that it affects their life, even resulting in missed days at work. Often, the condition can be remedied by undergoing a specific type of head movement under a doctor's supervision, according to researcher Dr. Ji-Soo Kim, of Seoul National University College of Medicine. But the new findings now suggest that for folks with BPPV, "taking a supplement of vitamin D and calcium is a...

Vitamin D Won't Reduce Risk of Depression

4 August 2020
Vitamin D Won`t Reduce Risk of DepressionTUESDAY, Aug. 4, 2020 (HealthDay News) -- For those battling debilitating depression, a new study delivers some bad news: Vitamin D supplements won't make a dent in improving mood. While the "sunshine vitamin" is often touted as an alternative way to protect against depression, vitamin D's efficacy has remained unknown, the researchers said. But "there was no significant benefit from the supplement for this purpose. It did not prevent depression or improve mood," said study author Dr. Olivia Okereke, of Massachusetts General Hospital in Boston. For the study, more than 18,000 men and women aged 50 or older were selected to take vitamin D3 or a placebo, for an average of five years. Many other studies have found that low levels of vitamin D were tied with a higher risk for...

More Americans Turning to Artificial Sweeteners, But Is...

29 July 2020
More Americans Turning to Artificial Sweeteners, But Is That a Healthy Move?WEDNESDAY, July 29, 2020 (HealthDay News) -- Americans may be heeding expert advice to reduce sugar intake. But instead of giving up sweets altogether, they're turning to certain sugar substitutes. A new study found that between 2002 and 2018, purchases of packaged food products containing sucralose (Splenda) jumped from 39% to 71%. Purchases of products containing a newer type of sweetener -- rebaudioside A (Stevia, Truvia) -- rose from 0.1% in 2002 to 26% in 2018. Not all sugar substitutes saw increased use, however. In 2002, 60% of households chose products containing Aspartame (Equal) compared to 49% by 2018. Use of the sweetener saccharin (Sweet'N Low) also declined. "Some of the messaging from public health folks, doctors and other health care professionals about the need...

Tecartus Approved for Treatment of Mantle Cell Lymphoma

27 July 2020
Tecartus Approved for Treatment of Mantle Cell LymphomaMONDAY, July 27, 2020 (HealthDay News) -- Tecartus (brexucabtagene autoleucel) received approval for the treatment of mantle cell lymphoma (MCL) in patients who have not responded to other treatment types or relapsed following treatment, the U.S. Food and Drug Administration announced Friday. Tecartus is a chimeric antigen receptor (CAR) T cell therapy and the first cell-based gene therapy approved for the treatment of MCL. Each dose of the drug is customized based on a patient's immune system. The approval was based on safety and efficacy data from a multicenter clinical trial of 60 adults with refractory or relapsed MCL. Patients were followed for at least six months after their first objective disease response. Sixty-two percent of patients achieved complete remission after...

Copyright © 2018 HealthDay. All rights reserved.